Screening for Discovery of Novel Peroxisome Proliferator-Activated Receptor-alpha and -gamma Agonists and Nuclear Factor-κB Inhibitors by Luciferase Reporter Gene Assays
Excerpt
Peroxisome proliferator-activated receptors (PPARs) are transcription factors that belong to the nuclear receptor super family and represent promising therapeutic targets for several inflammatory and metabolic disorders. Nuclear factor-κB (NF-κB) is also a well-known transcription factor that regulates genes involved in inflammation.[...]
Share and Cite
FAKHRUDIN, N.; VOGL, S.; PICKER, P.; HEISS, E.H.; SAUKEL, J.; REZNICEK, G.; KOPP, B.; ATANASOV, A.G.; DIRSCH, V.M. Screening for Discovery of Novel Peroxisome Proliferator-Activated Receptor-alpha and -gamma Agonists and Nuclear Factor-κB Inhibitors by Luciferase Reporter Gene Assays. Sci. Pharm. 2009, 77, 240. https://doi.org/10.3797/scipharm.oephg.21.PO-41
FAKHRUDIN N, VOGL S, PICKER P, HEISS EH, SAUKEL J, REZNICEK G, KOPP B, ATANASOV AG, DIRSCH VM. Screening for Discovery of Novel Peroxisome Proliferator-Activated Receptor-alpha and -gamma Agonists and Nuclear Factor-κB Inhibitors by Luciferase Reporter Gene Assays. Scientia Pharmaceutica. 2009; 77(Posters (PO)):240. https://doi.org/10.3797/scipharm.oephg.21.PO-41
Chicago/Turabian StyleFAKHRUDIN, N., S. VOGL, P. PICKER, E. H. HEISS, J. SAUKEL, G. REZNICEK, B. KOPP, A. G. ATANASOV, and V. M. DIRSCH. 2009. "Screening for Discovery of Novel Peroxisome Proliferator-Activated Receptor-alpha and -gamma Agonists and Nuclear Factor-κB Inhibitors by Luciferase Reporter Gene Assays" Scientia Pharmaceutica 77, Posters (PO): 240. https://doi.org/10.3797/scipharm.oephg.21.PO-41
